Literature DB >> 25049393

Regulatory effects of SKAR in interferon α signaling and its role in the generation of type I IFN responses.

Barbara Kroczynska1, Swarna Mehrotra1, Beata Majchrzak-Kita2, Ahmet Dirim Arslan1, Jessica K Altman3, Brady L Stein1, Brandon McMahon1, Piotr Kozlowski4, Philipp J Kahle5, Elizabeth A Eklund3, Eleanor N Fish2, Leonidas C Platanias6.   

Abstract

We provide evidence that S6 kinase 1 (S6K1) Aly/REF-like target (SKAR) is engaged in IFN-α signaling and plays a key role in the generation of IFN responses. Our data demonstrate that IFN-α induces phosphorylation of SKAR, which is mediated by either the p90 ribosomal protein S6 kinase (RSK) or p70 S6 kinase (S6K1), in a cell type-specific manner. This type I IFN-inducible phosphorylation of SKAR results in enhanced interaction with the eukaryotic initiation factor (eIF)4G and recruitment of activated RSK1 to 5' cap mRNA. Our studies also establish that SKAR is present in cap-binding CBP80 immune complexes and that this interaction is mediated by eIF4G. We demonstrate that inducible protein expression of key IFN-α-regulated protein products such as ISG15 and p21(WAF1/CIP1) requires SKAR activity. Importantly, our studies define a requirement for SKAR in the generation of IFN-α-dependent inhibitory effects on malignant hematopoietic progenitors from patients with chronic myeloid leukemia or myeloproliferative neoplasms. Taken altogether, these findings establish critical and essential roles for SKAR in the regulation of mRNA translation of IFN-sensitive genes and induction of IFN-α biological responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25049393      PMCID: PMC4128135          DOI: 10.1073/pnas.1405250111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Quality control of mRNA function.

Authors:  L E Maquat; G G Carmichael
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

2.  The yeast nuclear cap binding complex can interact with translation factor eIF4G and mediate translation initiation.

Authors:  P Fortes; T Inada; T Preiss; M W Hentze; I W Mattaj; A B Sachs
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

3.  Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20.

Authors:  Y Ishigaki; X Li; G Serin; L E Maquat
Journal:  Cell       Date:  2001-09-07       Impact factor: 41.582

4.  Structural basis of m7GpppG binding to the nuclear cap-binding protein complex.

Authors:  Guillermo Calero; Kristin F Wilson; Thi Ly; Jorge L Rios-Steiner; Jon C Clardy; Richard A Cerione
Journal:  Nat Struct Biol       Date:  2002-12

5.  The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling.

Authors:  Fabrice Lejeune; Yasuhito Ishigaki; Xiaojie Li; Lynne E Maquat
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

6.  Splicing enhances translation in mammalian cells: an additional function of the exon junction complex.

Authors:  Ajit Nott; Hervé Le Hir; Melissa J Moore
Journal:  Genes Dev       Date:  2004-01-15       Impact factor: 11.361

Review 7.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

Review 8.  Map kinase signaling pathways and hematologic malignancies.

Authors:  Leonidas C Platanias
Journal:  Blood       Date:  2003-03-06       Impact factor: 22.113

9.  Interaction of eukaryotic translation initiation factor 4G with the nuclear cap-binding complex provides a link between nuclear and cytoplasmic functions of the m(7) guanosine cap.

Authors:  L McKendrick; E Thompson; J Ferreira; S J Morley; J D Lewis
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

10.  The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.

Authors:  Howard L Kaufman; John M Kirkwood; F Stephen Hodi; Sanjiv Agarwala; Thomas Amatruda; Steven D Bines; Joseph I Clark; Brendan Curti; Marc S Ernstoff; Thomas Gajewski; Rene Gonzalez; Laura Jane Hyde; David Lawson; Michael Lotze; Jose Lutzky; Kim Margolin; David F McDermott; Donald Morton; Anna Pavlick; Jon M Richards; William Sharfman; Vernon K Sondak; Jeffrey Sosman; Susan Steel; Ahmad Tarhini; John A Thompson; Jill Titze; Walter Urba; Richard White; Michael B Atkins
Journal:  Nat Rev Clin Oncol       Date:  2013-08-27       Impact factor: 66.675

View more
  5 in total

1.  Interferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses.

Authors:  Barbara Kroczynska; Robert L Rafidi; Beata Majchrzak-Kita; Ewa M Kosciuczuk; Gavin T Blyth; Jacek Jemielity; Zofia Warminska; Diana Saleiro; Swarna Mehrotra; Ahmet Dirim Arslan; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

2.  Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.

Authors:  Jacquelyn R Bedsaul; Luna A Zaritsky; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2016-08-10       Impact factor: 2.607

3.  An NFκB Activity Calculator to Delineate Signaling Crosstalk: Type I and II Interferons Enhance NFκB via Distinct Mechanisms.

Authors:  Simon Mitchell; Ellen L Mercado; Adewunmi Adelaja; Jessica Q Ho; Quen J Cheng; Gourisankar Ghosh; Alexander Hoffmann
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 4.  Deciphering GRINA/Lifeguard1: Nuclear Location, Ca2+ Homeostasis and Vesicle Transport.

Authors:  Víctor Jiménez-González; Elena Ogalla-García; Meritxell García-Quintanilla; Albert García-Quintanilla
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

5.  PDIP46 (DNA polymerase δ interacting protein 46) is an activating factor for human DNA polymerase δ.

Authors:  Xiaoxiao Wang; Sufang Zhang; Rong Zheng; Fu Yue; Szu Hua Sharon Lin; Amal A Rahmeh; Ernest Y C Lee; Zhongtao Zhang; Marietta Y W T Lee
Journal:  Oncotarget       Date:  2016-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.